Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000213213 | SCV000270595 | likely benign | not specified | 2015-10-31 | criteria provided, single submitter | clinical testing | p.Ala245Gly in exon 3 of MYPN: This variant is not expected to have clinical sig nificance because it has been identified in 0.3% (28/10386) of African chromosom es by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; db SNP rs143574079). |
Labcorp Genetics |
RCV000229711 | SCV000291127 | likely benign | Dilated cardiomyopathy 1KK | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000252158 | SCV000320136 | likely benign | Cardiovascular phenotype | 2018-05-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001530400 | SCV000518056 | likely benign | not provided | 2020-08-18 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001530400 | SCV001922727 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001530400 | SCV001926735 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001530400 | SCV001975691 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003937835 | SCV004750609 | likely benign | MYPN-related disorder | 2021-10-29 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |